US 12018281
Cardiomyocyte maturation promoter
granted A61KA61K35/34
Quick answer
US patent 12018281 (Cardiomyocyte maturation promoter) held by Takeda Pharmaceutical Company Limited expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K35/34